Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
Br J Cancer
.
2018 Mar 20;118(6):e10.
doi: 10.1038/bjc.2017.469.
Epub 2018 Jan 9.
Authors
A F Hottinger
,
A Ben Aissa
,
V Espeli
,
D Squiban
,
N Dunkel
,
M I Vargas
,
T Hundsberger
,
N Mach
,
K Schaller
,
D C Weber
,
A Bodmer
,
P-Y Dietrich
PMID:
29315292
PMCID:
PMC5877431
DOI:
10.1038/bjc.2017.469
Abstract
This corrects the article DOI: 10.1038/bjc.2014.209.
Publication types
Published Erratum